These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20859201)

  • 1. The current state of recombinant allergens for immunotherapy.
    Pauli G; Malling HJ
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen-specific immunotherapy with recombinant allergens.
    Pauli G; Malling HJ
    Curr Top Microbiol Immunol; 2011; 352():43-54. PubMed ID: 21404096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials with recombinant allergens--three perspectives: industry.
    Narkus A; Kniest F; Menzel A; Meyer H; Sprung V
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():270-5; discussion 275-8. PubMed ID: 20799471
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen immunotherapy for birch pollen-allergic patients: recent advances.
    Moingeon P; Floch VB; Airouche S; Baron-Bodo V; Nony E; Mascarell L
    Immunotherapy; 2016 May; 8(5):555-67. PubMed ID: 27140409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immunotherapy, one century later.
    Passalacqua G; Bush RK
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):551-3. PubMed ID: 21971328
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives.
    Purohit A; Niederberger V; Kronqvist M; Horak F; Grönneberg R; Suck R; Weber B; Fiebig H; van Hage M; Pauli G; Valenta R; Cromwell O
    Clin Exp Allergy; 2008 Sep; 38(9):1514-25. PubMed ID: 18564326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant allergens for specific immunotherapy.
    Cromwell O; Häfner D; Nandy A
    J Allergy Clin Immunol; 2011 Apr; 127(4):865-72. PubMed ID: 21377719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials with recombinant allergens: research studies?
    Pauli G
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():257-64; discussion 264-5. PubMed ID: 20799469
    [No Abstract]   [Full Text] [Related]  

  • 10. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with recombinant molecules for allergy vaccination.
    Cromwell O; Niederberger V; Horak F; Fiebig H
    Curr Top Microbiol Immunol; 2011; 352():27-42. PubMed ID: 21562972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of molecular biology on allergen immunotherapy.
    Bush RK
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):557-8. PubMed ID: 21030836
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients.
    Marogna M; Spadolini I; Massolo A; Zanon P; Berra D; Chiodini E; Canonica WG; Passalacqua G
    Ann Allergy Asthma Immunol; 2007 Mar; 98(3):274-80. PubMed ID: 17378260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicutaneous immunotherapy.
    Scheurer S; Toda M
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():25-29. PubMed ID: 29108765
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergen immunotherapy: where is it now?
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):769-79. PubMed ID: 17337297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in immunotherapy for allergic diseases.
    El-Qutob D; Mencia G; Fernandez-Caldas E
    Recent Pat Inflamm Allergy Drug Discov; 2014 Jan; 8(1):24-35. PubMed ID: 24237114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New concepts in therapy of type I allergic diseases].
    Valenta R; Steinberger P; Vrtala S; Grote M; Laffer S; Sperr WR; Valent P; Kraft D; Scheiner O
    Wien Klin Wochenschr; 1993; 105(23):682-6. PubMed ID: 7508663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens.
    Valenta R; Linhart B; Swoboda I; Niederberger V
    Allergy; 2011 Jun; 66(6):775-83. PubMed ID: 21352238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen-specific immunotherapy with recombinant grass pollen allergens.
    Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
    J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological mechanisms of allergen-specific immunotherapy.
    Jutel M; Akdis CA
    Allergy; 2011 Jun; 66(6):725-32. PubMed ID: 21466562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.